Please login to the form below

Not currently logged in

Cellectis’ Mathieu Simon will serve as interim chief medical officer

He will take over the responsibilities of Loan Hoang-Sayag

Mathieu SimonCellectis has appointed Mathieu Simon to as interim chief medical officer, taking over the role from Loan Hoan-Sayag, who has left the French biopharmaceutical group to “pursue other opportunities”.

As current executive vice president and chief operating officer, Simon was previously chief executive officer of former subsidiary Cellectis Therapeutics has been “instrumental in the strategic and operational management of all therapeutic activities”.

His other roles include senior vice president, global pharma operations for Pierre Fabre and has held numerous senior roles with Wyeth Pharmaceuticals, before it was acquired by Pfizer for $68bn back in 2009.

16th October 2017

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Ashley Communications

Ashley Communications is a bespoke, independent medical communications consultancy consistently providing a unique director-delivered client service tailored to individual client...

Latest intelligence

figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...
The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...